Impact of Postprocedural High-Sensitivity C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk with ST-Segment Elevation Myocardial Infarction With Percutaneous Coronary Intervention

This study aimed to investigate the impact of high-sensitivity C-reactive protein (hsCRP) on Lipoprotein(a) [Lp(a)] associated cardiovascular risk in patients with ST-segment elevation myocardial infarction (STEMI) underwent percutaneous coronary intervention (PCI). A total of 2318 STEMI-PCI patients were retrospectively recruited, and further stratified based on postprocedural hsCRP levels ( ≥ 2 vs

Source: The American Journal of Cardiology - May 15, 2021 Category: Cardiology Authors: Ying Wang, Xiaoxiao Zhao, Peng Zhou, Chen Liu, Runzhen Chen, Zhaoxue Sheng, Jiannan Li, Jinying Zhou, Li Song, Hanjun Zhao, Hongbing Yan Source Type: research